These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1668630)

  • 1. [V-erbA oncogene, model of oncogenic activation of hormone receptor].
    Samarut J
    Ann Endocrinol (Paris); 1991; 52(6):397-401. PubMed ID: 1668630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA.
    Zenke M; Muñoz A; Sap J; Vennström B; Beug H
    Cell; 1990 Jun; 61(6):1035-49. PubMed ID: 1972036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myb-Ets fusion oncoprotein inhibits thyroid hormone receptor/c-ErbA and retinoic acid receptor functions: a novel mechanism of action for leukemogenic transformation by E26 avian retrovirus.
    Rascle A; Ferrand N; Gandrillon O; Samarut J
    Mol Cell Biol; 1996 Nov; 16(11):6338-51. PubMed ID: 8887663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of normal erythroid differentiation by the endogenous thyroid hormone and retinoic acid receptors: a possible target for v-erbA oncogene action.
    Schroeder C; Gibson L; Zenke M; Beug H
    Oncogene; 1992 Feb; 7(2):217-27. PubMed ID: 1347914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The leukaemia oncogene v-erbA: a dominant negative version of ligand dependent transcription factors that regulates red cell differentiation?
    Ghysdael J; Beug H
    Cancer Surv; 1992; 14():169-80. PubMed ID: 1358441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-ErbA, but not v-ErbA, competes with a putative erythroid repressor for binding to the carbonic anhydrase II promoter.
    Rascle A; Ghysdael J; Samarut J
    Oncogene; 1994 Oct; 9(10):2853-67. PubMed ID: 7916146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The v-erbA oncogene requires cooperation with tyrosine kinases to arrest erythroid differentiation induced by ligand-activated endogenous c-erbA and retinoic acid receptor.
    Schroeder C; Gibson L; Beug H
    Oncogene; 1992 Feb; 7(2):203-16. PubMed ID: 1347913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The carbonic anhydrase II gene, a gene regulated by thyroid hormone and erythropoietin, is repressed by the v-erbA oncogene in erythrocytic cells.
    Pain B; Melet F; Jurdic P; Samarut J
    New Biol; 1990 Mar; 2(3):284-94. PubMed ID: 2126201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors.
    Bauer A; Mikulits W; Lagger G; Stengl G; Brosch G; Beug H
    EMBO J; 1998 Aug; 17(15):4291-303. PubMed ID: 9687498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ontogeny of the v-erbA oncoprotein from the thyroid hormone receptor: an alteration in the DNA binding domain plays a role crucial for v-erbA function.
    Bonde BG; Sharif M; Privalsky ML
    J Virol; 1991 Apr; 65(4):2037-46. PubMed ID: 1672166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a domain required for oncogenic activity and transcriptional suppression by v-erbA and thyroid-hormone receptor alpha.
    Damm K; Evans RM
    Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10668-72. PubMed ID: 7902566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The viral erbA oncogene protein, a constitutive repressor in animal cells, is a hormone-regulated activator in yeast.
    Privalsky ML; Sharif M; Yamamoto KR
    Cell; 1990 Dec; 63(6):1277-86. PubMed ID: 1979758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The c-erbA alpha-encoded thyroid hormone receptor is phosphorylated in its amino terminal domain by casein kinase II.
    Glineur C; Bailly M; Ghysdael J
    Oncogene; 1989 Oct; 4(10):1247-54. PubMed ID: 2552374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional domains of the v-erbA protein necessary for oncogenesis are required for transcriptional activation in Saccharomyces cerevisiae.
    Smit-McBride Z; Privalsky ML
    Oncogene; 1993 Jun; 8(6):1465-75. PubMed ID: 8099219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo.
    Ciana P; Braliou GG; Demay FG; von Lindern M; Barettino D; Beug H; Stunnenberg HG
    EMBO J; 1998 Dec; 17(24):7382-94. PubMed ID: 9857194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A subpopulation of the avian erythroblastosis virus v-erbA protein, a member of the nuclear hormone receptor family, is glycosylated.
    Privalsky ML
    J Virol; 1990 Jan; 64(1):463-6. PubMed ID: 1967151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. V-erbA requires auxiliary proteins for dominant negative activity.
    Hermann T; Hoffmann B; Piedrafita FJ; Zhang XK; Pfahl M
    Oncogene; 1993 Jan; 8(1):55-65. PubMed ID: 8093812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of protein kinase C or cAMP-dependent protein kinase increases phosphorylation of the c-erbA-encoded thyroid hormone receptor and of the v-erbA-encoded protein.
    Goldberg Y; Glineur C; Gesquière JC; Ricouart A; Sap J; Vennström B; Ghysdael J
    EMBO J; 1988 Aug; 7(8):2425-33. PubMed ID: 2903825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic dissection of functional domains within the avian erythroblastosis virus v-erbA oncogene.
    Privalsky ML; Boucher P; Koning A; Judelson C
    Mol Cell Biol; 1988 Oct; 8(10):4510-7. PubMed ID: 2847034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of transformation by v-ErbA: substitution for steroid hormone receptor function in self renewal induction.
    Bauer A; Ulrich E; Andersson M; Beug H; von Lindern M
    Oncogene; 1997 Aug; 15(6):701-15. PubMed ID: 9264411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.